Southern Alberta Myeloma Patient Society

News & Updates

Dr. Neri Speaking at SAMPS Conference

Dr. Neri is a Clinical Associate Professor of Medicine, attending physician in the Hematology division at University of Calgary and member of the Arnie Charbonneau Cancer Institute. She received her medical degree at Magna Græcia University, Catanzaro, Italy in 2000. She has completed her specialty in Medical Oncology at Magna Græcia University, Catanzaro, Italy in 2005 and received a PhD in Molecular Oncology and Experimental Immunology in 2011. 

From 2003-2006 she was Research Associate at Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA under the mentorship of Dr. Kenneth Anderson and Dr. Nikhil Munshi. The main focus of her research is to investigate the genome signature associated with myeloma resistance to anti-MM agents and to identify druggable therapeutic targets in myeloma.

Dr. Neri is well published in the field and some of her research work included the development of the scid-hu myeloma model and the pre-clinical investigation of several classes of drugs in this disease. Several of these pre-clinically validated targets are currently in early phase I clinical studies (BAFF inhibitors, HDAC inhibitors, ITGB-7 and PARP inhibitors).

Dr. Neri has received national and international grants from several agencies including Myeloma Canada, Leukemia and Lymphoma Society, The International Multiple Myeloma Research Foundation and Canadian Institute of Health Research (CIHR).  She has presented her research at numerous national and international meetings and has chaired and participated in numerous international forums including the American Society of Hematology and the International Myeloma Workshop. 

Dr. Neri is currently a member of the American Society of Hematology and the scientific board of Myeloma Canada and is very active both in preclinical and clinical trial research in Myeloma.

We are pleased to have Dr. Neri as one of our presenters at the SAMPS 2021 Fall Conference on Saturday, October 23, 2021. This Conference will be open to all Myeloma patients, caregivers and family members. Check out the event listing for details about how you can participate.

Angela Craig